PLAINSBORO, N.J., Jan. 26, 2016 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced the availability of its newest insulin, Tresiba® (insulin degludec injection), a ...
Novo Nordisk announced the launch of Tresiba (insulin degludec) injection indicated to improve glycemic control in adults with diabetes. Novo Nordisk announced the launch of Tresiba (insulin degludec) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback